SPARTA Biodiscovery offers Facilitating nanoformulations for upcoming therapies.
SPARTA Biodiscovery has raised $4.3M in total funding. The most recent round was Seed. The last funding was announced in September 2023.
SPARTA Biodiscovery's investors include Sartorius.
SPARTA Biodiscovery is headquartered in London, United Kingdom.
SPARTA Biodiscovery offers Facilitating nanoformulations for upcoming therapies.
SPARTA Biodiscovery is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SPARTA Biodiscovery — Funding & Investors." VCBacked, September 28, 2023, https://www.vcbacked.co/company/sparta-biodiscovery. Accessed August 14, 2026.
VCBacked. (2023). SPARTA Biodiscovery — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/sparta-biodiscovery
{{cite web |title=SPARTA Biodiscovery — Funding & Investors |url=https://www.vcbacked.co/company/sparta-biodiscovery |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated